Results 261 to 270 of about 2,801,899 (401)

A2A adenosine receptor protects tumors from antitumor T cells

Proceedings of the National Academy of Sciences of the United States of America, 2006
A. Ohta, E. Gorelik, Simon J. Prasad, F. Ronchese, D. Lukashev, M. Wong, Xiaojun Huang, Sheila A. Caldwell, Kebin Liu, Patrick T. Smith, Jiang-fan Chen, E. Jackson, S. Apasov, S. Abrams, M. Sitkovsky   +14 more
semanticscholar   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

Advanced Science, EarlyView.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang, Jiangang Xu, Xinyu Zhou, Lu Che, Minghan Qiu, Yang Liu, Ming Gao, Zhen Yang   +7 more
wiley   +1 more source

Multisite Model of Allosterism for the Adenosine A1 Receptor

, 2021
Giuseppe Deganutti, Kerry Barkan, Graham Ladds, Christopher A. Reynolds   +3 more
openalex   +2 more sources

Mechanisms of Direct Electron Transfer Governed by Redox‐Active Conductive Carrier with Superior Wettability in Anaerobic Biofilms

Advanced Science, EarlyView.
A redox‐active conductive carrier of tannic acid‐modified iron‐biochar with superior wettability is demonstrated to regulate direct electron transfer at the anaerobic biofilm‐carrier interface by enhancing the cytochrome c‐mediated pathway. For the first time, integrated evidence from spectroscopy, electrochemical analyses, and metatranscriptomics ...
Junli Tian, Xiaoyuan Zhang, Lulu Xing, Bin Ji, Jinfeng Lu, Yu Liu   +5 more
wiley   +1 more source

Reduced adenosine receptor expression in ACS patients with no-reflow phenomenon undergoing primary PCI. [PDF]

Future Cardiol
Bagheri A, Alipour Parsa S, Namazi MH, Khaheshi I, Sohrabifar N.   +4 more
europepmc   +1 more source

Adenosine A2A receptor (ADORA2A); ecto-5′-nucleotidase (NT5E; NT; CD73) [PDF]

, 2013

openalex   +1 more source

LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice [PDF]

, 2018
Jeong, Lak Shin, Jeong, Se-Jin, Kim, Gyudong, Oh, Goo Taeg, Park, Jong-Gil, Yu, Jinha   +5 more
core   +1 more source

Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy

Advanced Science, EarlyView.
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley   +1 more source

A_2B adenosine receptor signaling and regulation. [PDF]

Purinergic Signal
Gao ZG, Haddad M, Jacobson KA.
europepmc   +1 more source

Two-Step Ligand-Directed Covalent Fluorescent Labeling of the Adenosine A ₁ -Receptor That Maintains Its Orthosteric Binding Site’s Availability to Bind Ligands

Chia-Yang Lin, Simon Platt, Joëlle Goulding, Stephen J. Briddon, Nicholas D. Kindon, Clare R. Harwood, Chih-Wei Lai, Barrie Kellam, Stephen J. Hill   +8 more
openalex   +1 more source